TOFACITINIB

Open Access
Radiographic Progression According to Baseline C-reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Treated with Tofacitinib or Adalimumab
Désirée van der Heijde, Dafna D. Gladman, Oliver FitzGerald, Arthur Kavanaugh, Daniela Graham, Cunshan Wang and Lara Fallon

The Journal of Rheumatology September 1 2019, 46 (9) 1089-1096; DOI: https://doi.org/10.3899/jrheum.180971
Open Access
Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies
Christina Charles-Schoeman, Désirée van der Heijde, Gerd R. Burmester, Peter Nash, Cristiano A.F. Zerbini, Carol A. Connell, Haiyun Fan, Kenneth Kwok, Eustratios Bananis and Roy Fleischmann

The Journal of Rheumatology February 1 2018, 45 (2) 177-187; DOI: https://doi.org/10.3899/jrheum.170486
Open Access
Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies
Jürgen Wollenhaupt, Joel Silverfield, Eun Bong Lee, Jeffrey R. Curtis, Susan P. Wood, Koshika Soma, Chudy I. Nduaka, Birgitta Benda, David Gruben, Hiroyuki Nakamura, Yoshihiro Komuro, Samuel H. Zwillich, Lisy Wang and Richard J. Riese

The Journal of Rheumatology May 1 2014, 41 (5) 837-852; DOI: https://doi.org/10.3899/jrheum.130683

Main menu